Insights into novel supramolecular complexes of two solid forms of Norfloxacin and β-Cyclodextrin

Journal of Pharmaceutical Sciences

Volumn 102, Issue 10, 2013, Pages 3717-3724

  Chattah, Ana K ^a   Mroue, Kamal H ^b   Pfund, Laura Y ^b   Ramamoorthy, Ayyalusamy ^b   Longhi, Marcela R ^a   Garnero, Claudia ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Characterization; Complexation; Cyclodextrins; FTIR; Norfloxacin; Polymorphism; Solid state NMR; X ray diffractometry

Indexed keywords

BETA CYCLODEXTRIN; NORFLOXACIN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; DRUG FORMULATION; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID STATE; SUPRAMOLECULAR CHEMISTRY; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

CHARACTERIZATION; COMPLEXATION; CYCLODEXTRINS; FTIR; NORFLOXACIN; POLYMORPHISM; SOLID STATE NMR; X-RAY DIFFRACTOMETRY;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; MAGNETIC RESONANCE SPECTROSCOPY; NORFLOXACIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84883830693     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23683     Document Type: Article

References (31)

1. Walsh RDB, Bradner MW, Fleischman S, Morales LA, Moulton B, Rodriguez-Hornedo N, Zaworotko M. 2003. Crystal engineering of the composition of pharmaceutical phases. Chem Commun 2:186-187.
2. Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee M, Guzman HR, Almarsson O. 2003. Crystal engineering of novel cocrystals of a triazole drug with 1, 4-dicarboxylic acids. J Am Chem Soc 125:8456-8457.
3. Lutker KM, Quiñones R, Xu J, Ramamoorthy A, Matzger AJ. 2011. Polymorphs and hydrates of acyclovir. J Pharm Sci 100:949-963.
4. Hilfiker R, Ed. 2006. Polymorphism in the pharmaceutical industry. Germany: Wiley-VCH Verlag GmbH & Co.
5. Mazuel C. 1991. In Analytical profiles of drug substances; Norfloxacin Florey K, Ed. Vol. 20. San Diego: Academic Press, pp 557-600.
6. Arredondo-García JL, Figueroa-Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos-Fabra A, Amábile-Cuevas CF, Hernández-Oliva GM, Olguín J, Cardeñosa-Guerra O 2004. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother 54:840-843.
7. Lindenberg M, Kopp S, Dressman JB. 2004. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58:265-278.
8. Olivera ME, Bistoni A, Anun H, Salinas A, Manzo RH. 2004. Ototopical ciprofloxacin in a glycerin vehicle for the treatment of acute external otitis. Ear Nose Throat J 83:625-638.
9. Barbas R, Martí F, Prohens R, Puigjaner C. 2006. Polymorphism of norfloxacin: Evidence of the enantiotropic relationship between polymorphs A and B. Cryst Growth Des 6:1463-1467.
10. Puigjaner C, Barbas R, Portell A, Font-Bardia M, Alcobé X, Prohens R. 2010. Revisiting of the solid state of norfloxacin. Cryst Growth Des 10:2948-2953.
11. Barbas R, Prohens R, Puigjaner C. 2007. A new polymorph of norfloxacin. J Therm Anal Cal 89:687-692.
12. Brewster ME, Loftsson TT. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645-666.
13. Corralo Spada J, Zapata Noreña CP, Ferreira Marczak LD, Tessaro IC. 2012. Study on the stability of β-carotene microencapsulated with pinhão (Araucaria angustifolia seeds) starch. Carbohyd Polym 89:1166-1173.
14. Munoz-Celaya AL, Ortiz-García M, Vernon-Carter EJ, Jauregui-Rincón J, Galindo E, Serrano-Carreón L 2012. Spray-drying microencapsulation of Trichoderma harzianum conidias in carbohydrate polymers matrices. Carbohyd Polym 88:1141-1148.
15. Garnero C, Chattah AK, Longhi M. 2013. Supramolecular complexes of maltodextrin and furosemide polymorphs: A new approach for delivery systems. Carbohyd Polym 94:292-300.
16. Zoppi A, Garnero C, Garro Linck Y, Chattah AK, Monti GA, Longhi M. 2011. Enalapril:β-CD complex: Stability enhancement in solid state. Carbohyd Polym 86:716-721.
17. 1 relaxation measurements. Mol Pharm 7:1667-1691.
18. Vogt FG, Strohmeier M. 2012. 2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes. Mol Pharm 9:3357-3374.
19. Fawaz F, Bonini F, Guyot M, Bildet J, Maury M, Lagueny AM. 1996. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. Int J Pharm 132:271-275.
20. Torres-Labandeira JJ, de Labra Pinon P, Perez-Marcos B, Alvarez-Lorenzo C, Vila-Jato JL 1998. Effect of norfloxacin complexation with β-cyclodextrin on the in vitro dissolution behaviour and its interaction with Mg2+ and Al3+. J Thermal Anal Calorim 51:1009-1021.
21. Dua K, Ramana MV, Singh Sara UV, Himaja M, Agrawal A, Garg V, Pabreja K. 2007. Investigation of enhancement of solubility of norfloxacin β-cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv 4:21-25.
22. Byrn SR, Pfeiffer RR, Stowell JG, Eds. 1999. Solid state chemistry of drugs. 2nd ed. SSCI, Inc.West Lafayette, Indiana
23. Bugay DE. 2001. Characterization of the solid-state: Spectroscopic techniques. Adv Drug Deliv Rev 48:43-65.
24. Harris RK. 1994. Nuclear magnetic resonance spectroscopy. London: Logman Scientific and Technical.
25. Harris RK. 2007. Applications of solid-state NMR to pharmaceutical polymorphism and related matters. J Pharm Pharmacol 59:225-239.
26. Geppi M, Mollica G, Borsacchi S, Veracini CA. 2008. Solid-state NMR studies of pharmaceutical systems. Appl Spectrosc Rev 43:202-302.
27. 1 relaxation ordered spectroscopy. J Magn Reson 202:135-139.
28. Mroue KH, MacKinnon N, Xu J, Zhu P, McNerny E, Kohn DH, Morris MD, Ramamoorthy A. 2012. High-resolution structural insights into bone: A solid-state NMR relaxation study utilizing paramagnetic doping. J Phys Chem B 116:11656-11661.
29. Khitrin AK, Fujiwara T, Akutsub H. 2003. Phase-modulated heteronuclear decoupling in NMR of solids. J Magn Reson 162:46-53.
30. Chongcharoen W, Byrn SR, Sutanthavibul N. 2008. Solid state interconversion between anhydrous norfloxacin and its hydrates. J Pharm Sci 97:473-489.
31. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. 1995. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 123:53-63.